SP

ARS Pharmaceuticals, Inc.

SPRY · Nasdaq

ARS Pharmaceuticals, Inc. (SPRY) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for ARS Pharmaceuticals, Inc. in 2026. The next earnings report is expected on November 17, 2026.

Earnings calendar

Next earnings date

17 Nov 2026

In 89 days

EPS estimate

-0.29

Revenue estimate

49.9M

Past earnings

13 Aug 2026
EPS actual
-0.63 (-31.9%)
estimate -0.48
Revenue actual
33.7M (+7.5%)
estimate 31.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
15 May 2026
EPS actual
-0.61 (-18.2%)
estimate -0.52
Revenue actual
22.7M (+2.2%)
estimate 22.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
09 Mar 2026
EPS actual
-0.41 (+4.6%)
estimate -0.43
Revenue actual
28.1M (+9.7%)
estimate 25.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
10 Nov 2025
EPS actual
-0.52 (-14.6%)
estimate -0.45
Revenue actual
32.5M (+13.4%)
estimate 28.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

ARS Pharmaceuticals missed consensus on EPS, posting a loss per share of $0.63 versus an expected loss of $0.4777, while revenue exceeded estimates at $33.66 million, 7.5% above expectations. In the prior quarter EPS likewise fell short of expectations while revenue also came in ahead of estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Richard E. Lowenthal
Employees
155
IPO date
04 Dec 2020
ISIN
US82835W1080
Website
ars-pharma.com

Frequently asked questions

When does ARS Pharmaceuticals, Inc. (SPRY) next report earnings?

ARS Pharmaceuticals, Inc. (SPRY) is scheduled to report earnings on November 17, 2026.

What was ARS Pharmaceuticals, Inc.'s most recent earnings date?

ARS Pharmaceuticals, Inc. (SPRY) last reported earnings on August 13, 2026.

Where is ARS Pharmaceuticals, Inc. stock listed?

ARS Pharmaceuticals, Inc. (SPRY) is listed on Nasdaq.